Skip to main content

ADVERTISEMENT

Primary PCI

Clinical Images
01/02/2022

Alessio Arrivi, MD, PhD1;  Nicola Bier, MD1;  Andrea Ascione, MD2;  Marcello Dominici, MD1

Alessio Arrivi, MD, PhD1;  Nicola Bie...
To our knowledge, this is the longest coronary thrombus ever reported to be removed in its entirety.
To our knowledge, this is the longest coronary thrombus ever reported to be removed in its entirety.
To our knowledge, this is the...
01/02/2022
Journal of Invasive Cardiology
VA-ECMO With IABP is Associated With Better Outcome Than VA-ECMO Alone in the Treatment of Cardiogenic Shock in ST-Elevation Myocardial Infarction
05/01/2021

Floris S. van den Brink, MD1,2;  Carlo Zivelonghi, MD3;  Tessel N. Vossenberg, MD1;  Gabe B. Bleeker, MD, PhD4;  Vivian L. Winia, MD5;  Krischan D. Sjauw, MD, PhD1;  Jurrien M. ten Berg, MD, PhD2

Floris S. van den Brink, MD1,2;  Carl...
This study assesses whether combining venoarterial extracorporeal membrane oxygenation (VA-ECMO) with intra-aortic balloon pump (IABP) improves outcomes in ST-segment elevation myocardial infarction (STEMI) over VA-ECMO alone.
This study assesses whether combining venoarterial extracorporeal membrane oxygenation (VA-ECMO) with intra-aortic balloon pump (IABP) improves outcomes in ST-segment elevation myocardial infarction (STEMI) over VA-ECMO alone.
This study assesses whether...
05/01/2021
Journal of Invasive Cardiology
Original Contribution
10/15/2018

Nicola S. Vos, MD1;  Giovanni Amoroso, MD, PhD1;  Maarten A. Vink, MD, PhD1;  Moniek Maarse, MD2;  Rob Adams, MSc3;  Jean-Paul R. Herrman, MD, PhD1;  Mark S. Patterson, MD, PhD1;  Ren√® J. van der Schaaf, MD, PhD1;  Ton Slagboom, MD1;  Robbert J. de Winter, MD, PhD3

Nicola S. Vos, MD1;  Giovanni Amoroso...
Pretreatment with P2Y12 inhibitors before primary percutaneous coronary intervention can reduce the incidence of major adverse cardiovascular event rate in ST-segment elevation myocardial infarction patients. We investigated differences in...
Pretreatment with P2Y12 inhibitors before primary percutaneous coronary intervention can reduce the incidence of major adverse cardiovascular event rate in ST-segment elevation myocardial infarction patients. We investigated differences in...
Pretreatment with P2Y12...
10/15/2018
Journal of Invasive Cardiology
Original Contribution
03/15/2017

Fredy El Sakr, MD;  Mohamad Kenaan, MD;  Daniel Menees, MD;  Milan Seth, BS, MS;  Hitinder S. Gurm, MD

Fredy El Sakr, MD;  Mohamad Kenaan, M...
Recent data demonstrate that mortality of patients with ST-elevation myocardial infarction (STEMI) has not changed despite dramatic reduction in door-to-balloon times. Identifying potential areas in care that can be further optimized to...
Recent data demonstrate that mortality of patients with ST-elevation myocardial infarction (STEMI) has not changed despite dramatic reduction in door-to-balloon times. Identifying potential areas in care that can be further optimized to...
Recent data demonstrate that...
03/15/2017
Journal of Invasive Cardiology